相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function
W. Sean Davidson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2022)
Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study
David G. Thomas et al.
JOURNAL OF LIPID RESEARCH (2021)
A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery disease
Qingyuan Zhao et al.
ELIFE (2021)
HDL in the 21st Century A Multifunctional Roadmap for Future HDL Research
Anand Rohatgi et al.
CIRCULATION (2021)
Artificial high-density lipoprotein-mimicking nanotherapeutics for the treatment of cardiovascular diseases
Hongliang He et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)
Changing Perspectives on HDL: From Simple Quantity Measurements to Functional Quality Assessment
Himani Thakkar et al.
JOURNAL OF LIPIDS (2021)
HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies
Guo-Chao Zhong et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes
Shuhui Wang Lorkowski et al.
BIOMOLECULES (2020)
Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity A Pooled Cohort Analysis
Kavisha Singh et al.
CIRCULATION (2020)
HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study
Monika Hunjadi et al.
SCIENTIFIC REPORTS (2020)
High-density lipoprotein characteristics and coronary artery disease: a Mendelian randomization study
Albert Prats-Uribe et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
A Novel Cell-Free Fluorescent Assay for HDL Function: Low Apolipoprotein A1 Exchange Rate Associated with Increased Incident Cardiovascular Events
Shuhui Wang Lorkowski et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes
Martin Heier et al.
ATHEROSCLEROSIS (2019)
High-Density Lipoprotein Cholesterol and All-Cause and Cause-Specific Mortality Among the Elderly
Zhi-Hao Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Very high high-density lipoprotein cholesterol is associated with increased all-cause mortality in South Koreans
In-Hwan Oh et al.
ATHEROSCLEROSIS (2019)
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque The Multi-Ethnic Study of Atherosclerosis
Steven Shea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Development and Validation of Apolipoprotein AI-Associated Lipoprotein Proteome Panel for the Prediction of Cholesterol Efflux Capacity and Coronary Artery Disease
Zhicheng Jin et al.
CLINICAL CHEMISTRY (2019)
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques
Panagiotis Fotakis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients
Andreas Gille et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells
Yuna Horiuchi et al.
BIOSCIENCE REPORTS (2018)
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis
Marit Westerterp et al.
CIRCULATION (2018)
Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study
Aya Hirata et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk
Kavisha Singh et al.
JOURNAL OF THORACIC DISEASE (2018)
Trials and Tribulations of CETP Inhibitors
Alan R. Tall et al.
CIRCULATION RESEARCH (2018)
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial A Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA CARDIOLOGY (2018)
Genetics of blood lipids among ∼300,000 multi-ethnic participants of the Million Veteran Program
Derek Klarin et al.
NATURE GENETICS (2018)
Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality inmen and women: two prospective cohort studies
Christian M. Madsen et al.
EUROPEAN HEART JOURNAL (2017)
A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans
Marina Cuchel et al.
JOURNAL OF LIPID RESEARCH (2017)
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A. Michael Lincoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cholesterol Uptake Capacity: A New Measure of HDL Functionality for Coronary Risk Assessment
Amane Harada et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2017)
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Amit V. Khera et al.
CIRCULATION (2017)
Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice
Marit Westerterp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity
Svetlana A. Didichenko et al.
CIRCULATION RESEARCH (2016)
Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration
Jeffrey S. Monette et al.
CIRCULATION RESEARCH (2016)
High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among US Veterans
Benjamin Bowe et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions The CANHEART Study
Dennis T. Ko et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Paolo Zanoni et al.
SCIENCE (2016)
Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins
Andrea E. Bochem et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity
Mark S. Borja et al.
JOURNAL OF LIPID RESEARCH (2015)
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Effects of Native and Myeloperoxidase-Modified Apolipoprotein A-I on Reverse Cholesterol Transport and Atherosclerosis in Mice
Bernd Hewing et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
An abundant dysfunctional apolipoprotein A1 in human atheroma
Ying Huang et al.
NATURE MEDICINE (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Coronary Heart Disease Risks Associated with High Levels of HDL Cholesterol
John T. Wilkins et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
ABCA1 Mediates Unfolding of Apolipoprotein AI N Terminus on the Cell Surface Before Lipidation and Release of Nascent High-Density Lipoprotein
Shuhui Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
Xin-Min Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Macrophages Increases Inflammation and Accelerates Atherosclerosis in Mice
Marit Westerterp et al.
CIRCULATION RESEARCH (2013)
Niacin: a long history, but a questionable future
Henry N. Ginsberg et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
Richard Haynes et al.
EUROPEAN HEART JOURNAL (2013)
Native High Density Lipoproteins (HDL) Interfere with Platelet Activation Induced by Oxidized Low Density Lipoproteins (OxLDL)
Sigrun Badrnya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
Ying Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis
Mark S. Borja et al.
PLOS ONE (2013)
Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport
Robert S. Rosenson et al.
CIRCULATION (2012)
LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals
Christiane L. Haase et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Genetic Inhibition of CETP, Ischemic Vascular Disease and Mortality, and Possible Adverse Effects
Trine Holm Johannsen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
Robert S. Rosenson et al.
CLINICAL CHEMISTRY (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
Margarita de la Llera-Moya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
High-density lipoprotein heterogeneity and function in reverse cholesterol transport
George H. Rothblat et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Exchange of Apolipoprotein A-I between Lipid-associated and Lipid-free States A POTENTIAL TARGET FOR OXIDATIVE GENERATION OF DYSFUNCTIONAL HIGH DENSITY LIPOPROTEINS
Giorgio Cavigiolio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation
Laurent Yvan-Charvet et al.
SCIENCE (2010)
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
Karim El Harchaoui et al.
ANNALS OF INTERNAL MEDICINE (2009)
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
Samia Mora et al.
CIRCULATION (2009)
Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle
Arundhati Undurti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Apolipoprotein A-I Tryptophan Substitution Leads to Resistance to Myeloperoxidase-Mediated Loss of Function
Dao-Quan Peng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
Ruth Frikke-Schmidt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies
Wim A. van der Steeg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Endothelial and antithrombotic actions of HDL
Chieko Mineo et al.
CIRCULATION RESEARCH (2006)
Identification of the cAMP-responsive enhancer of the murine ABCA1 gene - Requirement for CREB1 and STAT3/4 elements
W Le Goff et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I
D Seetharam et al.
CIRCULATION RESEARCH (2006)
Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo
YZ Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux
BF Asztalos et al.
JOURNAL OF LIPID RESEARCH (2005)
ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I
JD Smith et al.
JOURNAL OF LIPID RESEARCH (2004)
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
LM Zheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
N Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Change in α1 HDL concentration predicts progression in coronary artery stenosis
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Diabetes, plasma insulin, and cardiovascular disease - Subgroup analysis from the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)
HB Rubins et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues
M Van Eck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice
A Braun et al.
CIRCULATION RESEARCH (2002)
分享论文
